Detection of Oral and Throat Cancers Using OralViome Cancer Testing System

Launched by VIOME · Jul 5, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new test called the OralViome Cancer Testing System, which aims to detect oral and throat cancers early by analyzing saliva. The focus is on identifying conditions like oral squamous cell carcinoma (OSCC) and oropharyngeal cancer (OPC), as well as premalignant lesions that could lead to cancer. The study is currently recruiting participants at existing clinical sites, and it is open to everyone aged 18 and older who has been diagnosed with OSCC or OPC, as well as those with certain oral premalignant disorders.

To participate, individuals must provide informed consent and be able to follow the study's instructions. However, pregnant individuals, those using fertility medications, or people with active infections are not eligible. If you join the study, you can expect to undergo a simple saliva test, which is designed to help detect these cancers at an earlier stage. This research could play a significant role in improving early detection and potentially saving lives, so your participation could make a difference in cancer care.

Gender

ALL

Eligibility criteria

• • Inclusion Criteria
• • Signed Informed Consent obtained
• • 18 years and older
• • At a high risk of developing oral or throat cancer based on clinician's discretion
• • Exclusion Criteria
• • Pregnancy
• • Use of fertility enhancing medications